As of 2026-03-31, 拜耳医药保健（Bayer）'s data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 11.5 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 拜耳医药保健（Bayer）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
拜耳医药保健（Bayer）'s Mention Rate is 0.00%, lower than 0.6% of competitors
拜耳医药保健（Bayer）'s First Mention is 0.00%, lower than 0.9% of competitors
拜耳医药保健（Bayer）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
拜耳医药保健（Bayer）'s Positive Rate is 0.00%, lower than 8.9% of competitors
拜耳医药保健（Bayer）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 恒恒瑞医药 | 65.22% | 20.29% | 33.33% | 60.87% | 5.8% | View Details |
| 云云南白药 | 20.29% | 0% | 0% | 14.49% | 0% | View Details |
| 复复星医药 | 17.39% | 0% | 0% | 11.59% | 0% | View Details |
| 上上海医药 | 15.94% | 0% | 0% | 7.25% | 5.8% | View Details |
| 同同仁堂 | 8.7% | 0% | 0% | 1.45% | 5.8% | View Details |
| 齐齐鲁制药 | 7.25% | 0% | 0% | 4.35% | 0% | View Details |
| 拜拜耳医药保健（Bayer） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
